All Pharma News
Oak Hill Bio, Chiesi Enroll First BPD Prevention Phase 2b

Oak Hill Bio, Chiesi Enroll First BPD Prevention Phase 2b
PR NEWSWIRE
17 May 2024
Share Share
Chiesi Group signs MoU with Karolinska Institutet to tackle urgent challenges

Chiesi Group signs MoU with Karolinska Institutet to tackle urgent challenges
PHARMABIZ
16 May 2024
Share Share
Chiesi Group Forges Allianc, Karolinska to Tackle Urgent Health Challenges

Chiesi Group Forges Allianc, Karolinska to Tackle Urgent Health Challenges
PHARMIWEB
15 May 2024
Share Share
Sanofi, Pfizer, AZ lead biopharma industry investment in France

Sanofi, Pfizer, AZ lead biopharma industry investment in France
Kevin Dunleavy FIERCE PHARMA
13 May 2024
Share Share
Gossamer Bio and Chiesi partner for pulmonary hypertension treatment

Gossamer Bio and Chiesi partner for pulmonary hypertension treatment
PHARMACEUTICAL TECHNOLOGY
06 May 2024
Share Share
Gossamer Bio and Chiesi Group collaborate on Seralutinib for pulmonary diseases.

Gossamer Bio and Chiesi Group collaborate on Seralutinib for pulmonary diseases.
BUSINESSWIRE
06 May 2024
Share Share
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition

Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
REUTERS
06 May 2024
Share Share
Chiesi champions new inhaler propellant to reduce carbon footprint

Chiesi champions new inhaler propellant to reduce carbon footprint
Phalguni Deswal PHARMACEUTICAL TECHNOLOGY
22 Apr 2024
Share Share
Chiesi Global Presents Long-Term Data on Treatment with Velmanase Alfa

Chiesi Global Presents Long-Term Data on Treatment with Velmanase Alfa
PR NEWSWIRE
08 Feb 2024
Share Share
Chiesi Group and Oak Hill Bio announce License and Development Agreement

Chiesi Group and Oak Hill Bio announce License and Development Agreement
BUSINESSWIRE
09 Jan 2024
Share Share